Latest Commercial Revenue News

Artrya Limited has secured a five-year, US$0.6 million contract with Tanner Health, marking its inaugural commercial revenue in the U.S. market for its AI-powered Salix Coronary Anatomy platform.

AVITA Medical reported a strong first quarter with revenues up 67% to $18.5 million, driven by expanded commercial sales and new product introductions. Despite a narrower net loss, the company faces ongoing challenges from revenue covenants and macroeconomic pressures.

AVITA Medical reveals a bold expansion plan targeting a $3.5 billion U.S. acute wound care market by 2025, driven by a multi-product portfolio and sustained revenue growth.

AVITA Medical reported a robust 67% increase in first quarter 2025 revenue, driven by new product launches and a strategic commercial overhaul, while reaffirming its full-year growth and profitability targets.

Control Bionics reports its strongest US revenue in years alongside Australia’s best quarter since 2022, propelled by new product launches and strategic investments.

Knosys Limited reports a record Annual Recurring Revenue run rate of $9.8 million, driven by strong enterprise renewals and new customer wins, alongside the launch of its next-generation Libero library app and upgraded LMS.

Intelligent Monitoring Group Limited (IMG) has agreed to acquire KOBE Pty Ltd for an initial $6.98 million, aiming to expand its commercial security footprint in Queensland and boost FY25 EBITDA by approximately $2.5 million.

AVITA Medical reported a strong 30% increase in Q4 2024 commercial revenue and amended its credit agreement with OrbiMed to adjust revenue covenants through 2026. The company is poised for significant growth with new product rollouts and expects profitability by year-end 2025.

AVITA Medical's Q4 2024 earnings reveal strong commercial growth alongside the launch of Cohealyx, a novel collagen-based skin substitute that promises to transform acute wound care.

AVITA Medical reported a robust 30% increase in Q4 2024 commercial revenue alongside key FDA clearances, setting the stage for ambitious growth in 2025.

IODM Limited has achieved a significant milestone in its UK Education segment, raising its minimum monthly revenue threshold by 50% to GBP75k and outperforming half-year revenue forecasts.

Spenda Limited has reported a record-breaking quarter with cash receipts soaring 160% year-on-year and payment volumes more than doubling, signaling strong momentum as it advances toward profitability.